Mylan to Pay SEC $30M over EpiPen Pricing
The EpiPen drug maker has reached a settlement over a lawsuit with the Securities and Exchange Commission.
September 29, 2019
Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial
All eyes were on Oklahoma last week, when the first case in a flood of litigation against opioid drug manufacturers began Tuesday.
June 3, 2019